*Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology
‡Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart
†University of Tübingen, Tübingen
§Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm
∥Department of Pediatric Oncology, Hematology and Clinical Immunology, University Children’s Hospital, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf
#Institute of Pathology, Universität Würzburg and Comprehensive Cancer Center Mainfranken (CCCMF), Würzburg, Germany
¶Service d’Anatomie Pathologie, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France
Conflicts of Interest and Source of Funding: Supported by the German José Carreras Leukämie-Stiftung (DJCLS R 10/28) and the Robert Bosch-Stiftung (Project O3), Stuttgart, Germany. The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.
Correspondence: German Ott, MD, Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Auerbachstraße 110, Stuttgart 70376, Germany (e-mail: [email protected]).